We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$106B
AUM Growth
+$2.27B
Cap. Flow
-$488M
Cap. Flow %
-0.46%
Top 10 Hldgs %
30.07%
Holding
4,478
New
179
Increased
2,056
Reduced
1,848
Closed
61

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$101M
2
GEV icon
GE Vernova
GEV
+$75.4M
3
CRH icon
CRH
CRH
+$48.5M
4
CRWD icon
CrowdStrike
CRWD
+$45.8M
5
DELL icon
Dell
DELL
+$35.8M

Sector Composition

Rank Sector Weight
1 Technology 30.98%
2 Financials 12.55%
3 Healthcare 11.48%
4 Consumer Discretionary 10.52%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOUS
2476
DELISTED
Anywhere Real Estate
HOUS
$597K ﹤0.01%
180,420
-183,331
-50% -$857K
SLQT icon
2477
SelectQuote
SLQT
$121M
$597K ﹤0.01%
216,163
+1,598
+0.7% +$3.85K
ATXS
2478
DELISTED
Astria Therapeutics
ATXS
$595K ﹤0.01%
65,375
+2,556
+4% +$25K
KYO
2479
DELISTED
Kyocera Adr
KYO
$594K ﹤0.01%
51,774
+1,328
+3% +$15.2K
FFIC
2480
DELISTED
Flushing Financial
FFIC
$593K ﹤0.01%
45,129
-113
-0.2% -$1.38K
WLDN icon
2481
Willdan Group
WLDN
$1.3B
$591K ﹤0.01%
20,494
+1,818
+10% +$54.2K
VLUE icon
2482
iShares MSCI USA Value Factor ETF
VLUE
$9.44B
$590K ﹤0.01%
+5,700
New +$588K
ALNT icon
2483
Allient
ALNT
$1.92B
$589K ﹤0.01%
23,318
+4,392
+23% +$126K
HCAT icon
2484
Health Catalyst
HCAT
$128M
$582K ﹤0.01%
91,111
+7,589
+9% +$48.7K
CHGG icon
2485
Chegg
CHGG
$102M
$579K ﹤0.01%
183,347
+12,153
+7% +$60.4K
KRNY icon
2486
Kearny Financial
KRNY
$599M
$579K ﹤0.01%
94,147
-2,105
-2% -$12K
TRC icon
2487
Tejon Ranch
TRC
$451M
$579K ﹤0.01%
33,924
+770
+2% +$12.8K
TNGX icon
2488
Tango Therapeutics
TNGX
$4.41B
$578K ﹤0.01%
67,340
-4,097
-6% -$31.7K
NTT
2489
DELISTED
Nippon Telegraph & Telephone
NTT
$578K ﹤0.01%
24,371
+1,132
+5% +$26.8K
NICE icon
2490
Nice
NICE
$5.97B
$577K ﹤0.01%
3,358
+269
+9% +$55.3K
DHIL
2491
DELISTED
Diamond Hill
DHIL
$577K ﹤0.01%
4,099
+69
+2% +$10.4K
ACRE
2492
Ares Commercial Real Estate
ACRE
$270M
$575K ﹤0.01%
86,466
+1,797
+2% +$12.4K
FMX icon
2493
Fomento Económico Mexicano
FMX
$41.7B
$575K ﹤0.01%
5,338
-1,088
-17% -$127K
GCMG icon
2494
GCM Grosvenor
GCMG
$820M
$574K ﹤0.01%
58,772
+1,402
+2% +$13.5K
VYGR icon
2495
Voyager Therapeutics
VYGR
$201M
$573K ﹤0.01%
72,461
+26,014
+56% +$218K
ABUS icon
2496
Arbutus Biopharma
ABUS
$915M
$572K ﹤0.01%
185,067
+14,607
+9% +$43.8K
SMBK icon
2497
SmartFinancial
SMBK
$888M
$572K ﹤0.01%
24,147
+361
+2% +$7.81K
BYND icon
2498
Beyond Meat
BYND
$277M
$570K ﹤0.01%
84,961
+1,098
+1% +$7.79K
AMPS
2499
DELISTED
Altus Power
AMPS
$569K ﹤0.01%
145,233
+20,175
+16% +$83.9K
PHAT icon
2500
Phathom Pharmaceuticals
PHAT
$692M
$568K ﹤0.01%
55,178
+8,075
+17% +$83.2K

Similar funds

RhumbLine Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, RhumbLine Advisers held 4,478 positions worth $106B, up 2.2% from $104B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

RhumbLine Advisers's Q2 2024 filing shows 179 new, 2,056 increased, 1,848 reduced and 61 closed positions. Its largest new stake was GE Vernova: 475,685 shares worth $81.6M. The largest sale was iShares Russell 1000 ETF, an estimated $180M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q2 2024 buy was GE Vernova: 475,685 shares worth $81.6M.
  • RhumbLine Advisers added most to ExxonMobil in Q2 2024, an estimated $101M increase.
  • RhumbLine Advisers's biggest Q2 2024 reduction was iShares Russell 1000 ETF, cutting an estimated $180M.
  • RhumbLine Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $121M.
  • RhumbLine Advisers's ten largest holdings make up 30% of its $106B portfolio in Q2 2024.
  • RhumbLine Advisers opened 179 new positions and closed 61 in Q2 2024.
  • RhumbLine Advisers's portfolio value rose 2.2% quarter-over-quarter to $106B.

Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.